Your browser doesn't support javascript.
loading
A novel LPS-responsive beige-like anchor protein (LRBA) mutation presents with normal cytotoxic T lymphocyte-associated protein 4 (CTLA-4) and overactive TH17 immunity.
De Bruyne, Marieke; Bogaert, Delfien J; Venken, Koen; Van den Bossche, Lien; Bonroy, Carolien; Roels, Lisa; Tavernier, Simon J; van de Vijver, Els; Driessen, Ann; van Gijn, Marielle; Gámez-Diaz, Laura; Elewaut, Dirk; Grimbacher, Bodo; Haerynck, Filomeen; Moes, Nicolette; Dullaers, Melissa.
Affiliation
  • De Bruyne M; Clinical Immunology Research Lab, Department of Pulmonary Medicine, Ghent University Hospital, Ghent, Belgium; Center for Primary Immunodeficiency, Jeffrey Modell Diagnosis and Research Centre, Ghent University Hospital, Ghent, Belgium; Center for Medical Genetics, Ghent University and Ghent Univers
  • Bogaert DJ; Clinical Immunology Research Lab, Department of Pulmonary Medicine, Ghent University Hospital, Ghent, Belgium; Center for Primary Immunodeficiency, Jeffrey Modell Diagnosis and Research Centre, Ghent University Hospital, Ghent, Belgium; Center for Medical Genetics, Ghent University and Ghent Univers
  • Venken K; Department of Rheumatology, Ghent University Hospital, Ghent, Belgium; Unit for Molecular Immunology and Inflammation, VIB-UGent Inflammation Research Center, Ghent, Belgium.
  • Van den Bossche L; Clinical Immunology Research Lab, Department of Pulmonary Medicine, Ghent University Hospital, Ghent, Belgium; Center for Primary Immunodeficiency, Jeffrey Modell Diagnosis and Research Centre, Ghent University Hospital, Ghent, Belgium.
  • Bonroy C; Center for Primary Immunodeficiency, Jeffrey Modell Diagnosis and Research Centre, Ghent University Hospital, Ghent, Belgium; Department of Laboratory Medicine, Ghent University Hospital, Ghent, Belgium.
  • Roels L; Clinical Immunology Research Lab, Department of Pulmonary Medicine, Ghent University Hospital, Ghent, Belgium; Center for Primary Immunodeficiency, Jeffrey Modell Diagnosis and Research Centre, Ghent University Hospital, Ghent, Belgium.
  • Tavernier SJ; Clinical Immunology Research Lab, Department of Pulmonary Medicine, Ghent University Hospital, Ghent, Belgium; Center for Primary Immunodeficiency, Jeffrey Modell Diagnosis and Research Centre, Ghent University Hospital, Ghent, Belgium; Laboratory of Immunoregulation, VIB-UGent Inflammation Research
  • van de Vijver E; Department of Pediatric Gastroenterology, Antwerp University Hospital, Edegem, Belgium; Laboratory of Experimental Medicine and Pediatrics, Faculty of Medicine and Health Science, University of Antwerp, Antwerp, Belgium.
  • Driessen A; Department of Pathology, Antwerp University Hospital, Edegem, Belgium; Molecular imaging, Pathology, Radiotherapy & Oncology (MIPRO), Faculty of Medicine and Healthcare Sciences, University of Antwerp, Antwerp, Belgium.
  • van Gijn M; Department of Medical Genetics, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Gámez-Diaz L; Center for Chronic Immunodeficiency, University Medical Center of Freiburg, University of Freiburg, Freiburg, Germany.
  • Elewaut D; Department of Rheumatology, Ghent University Hospital, Ghent, Belgium; Unit for Molecular Immunology and Inflammation, VIB-UGent Inflammation Research Center, Ghent, Belgium.
  • Grimbacher B; Center for Chronic Immunodeficiency, University Medical Center of Freiburg, University of Freiburg, Freiburg, Germany.
  • Haerynck F; Clinical Immunology Research Lab, Department of Pulmonary Medicine, Ghent University Hospital, Ghent, Belgium; Center for Primary Immunodeficiency, Jeffrey Modell Diagnosis and Research Centre, Ghent University Hospital, Ghent, Belgium; Department of Pediatrics, Division of Pediatric Immunology and
  • Moes N; Department of Pediatric Gastroenterology, Antwerp University Hospital, Edegem, Belgium; Laboratory of Experimental Medicine and Pediatrics, Faculty of Medicine and Health Science, University of Antwerp, Antwerp, Belgium. Electronic address: Nicolette.Moes@uza.be.
  • Dullaers M; Clinical Immunology Research Lab, Department of Pulmonary Medicine, Ghent University Hospital, Ghent, Belgium; Center for Primary Immunodeficiency, Jeffrey Modell Diagnosis and Research Centre, Ghent University Hospital, Ghent, Belgium; Laboratory of Immunoregulation, VIB-UGent Inflammation Research
J Allergy Clin Immunol ; 142(6): 1968-1971, 2018 12.
Article de En | MEDLINE | ID: mdl-30193839
Sujet(s)
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Lymphocytes T régulateurs / Protéines adaptatrices de la transduction du signal / Cellules Th17 / Antigène CTLA-4 / Déficits immunitaires Type d'étude: Risk_factors_studies Limites: Child, preschool / Female / Humans Langue: En Journal: J Allergy Clin Immunol Année: 2018 Type de document: Article Pays de publication: États-Unis d'Amérique
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Lymphocytes T régulateurs / Protéines adaptatrices de la transduction du signal / Cellules Th17 / Antigène CTLA-4 / Déficits immunitaires Type d'étude: Risk_factors_studies Limites: Child, preschool / Female / Humans Langue: En Journal: J Allergy Clin Immunol Année: 2018 Type de document: Article Pays de publication: États-Unis d'Amérique